menu close
pathai.com
Pathai-Logo

PathAI Stock

Company Profile:

PathAI is a biotechnology company focused on improving patient outcomes through AI-powered pathology solutions. Founded to enhance the accuracy and efficiency of medical diagnoses, PathAI collaborates with biopharmaceutical companies, laboratories, and clinicians to provide advanced diagnostic tools.

Sign up for SecondMarket™ to view the market and buy or sell PathAI Stock
Buy + Sell

PathAI Funding

Sign up to gain insights into PathAI funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Apr 11, 2021 Series C 165.00M
Price
Valuation
Nov 04, 2019 Series B 15.00M
Price
Valuation
Apr 09, 2019 Series B 60.00M
Price
Valuation
Oct 18, 2017 Series A 3.47M
Price
Valuation
Oct 18, 2017 Series A 165.00K
Price
Valuation
Oct 18, 2017 Series A 11.10M
Price
Valuation
Oct 18, 2017 Series A 210.00K
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

Leverage Your Equity to Help Achieve More.

PathAI Management Team

  • Director

    Michelle Dipp

  • Co-Founder, CEO, Director

    Andrew Beck

  • Chief Compliance Officer and Associate General Counsel

    Christian Krautkramer

  • Chief of Staff

    Tafadzwa Muguwe

  • Chief People Officer

    Liz Storti

  • Director

    Stanley N. Lapidus

  • Chief Medical Officer

    Eric Walk

  • Chief Scientific Officer

    Mike Montalto

  • Director

    Jeffrey Leiden

  • Chief Commercial Officer, Diagnostics

    Debora Greenblatt

  • Director

    Aditya Khosla

  • Chief Operating Officer

    Tiffany Freitas

PathAI Major Investors

  • Merck Global Health Innovation Fund LLC

  • Biospring Management, LLC

  • Adage Inc.

  • Pillar Companies

  • Biospring Management, LLC

  • Bristol-Myers Squibb Company

  • Kaiser Permanente Ventures

  • KdT Ventures

  • Refactor Capital

  • General Catalyst Partners LLC

  • D1 Capital Partners

  • 8VC

  • Polaris Partners

  • Tiger Global Management LLC

  • Danhua Capital LP

  • General Atlantic LLC

Learn More About PathAI Stock

Buy PathAI Stock
01

PathAI stock does not trade on public stock exchanges. PathAI stock is considered a private security and you need to be an accredited investor to trade shares. To invest in PathAI stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell PathAI Stock
02

PathAI Stock does not trade on public stock exchanges. In order to sell PathAI shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

PathAI Stock Price
03

PathAI does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view PathAI share price and other valuable private market data.

Read more about secondary market private company stock prices:

PathAI Stock Ticker Symbol
04

There is no ticker symbol for PathAI stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell PathAI Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell PathAI stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in PathAI Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in PathAI stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

PathAI Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

PathAI IPO
08

PathAI is a private company and has not had an IPO. There is currently no PathAI IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to PathAI IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell PathAI Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Color-Logo

Color Health

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

A new biopharmaceutical company using revolutionary technology to discover novel treatments for life-threatening diseases.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Inscriptainc-Logo

Inscripta

Biomanufacturing and genome engineering.

Kallyope-Logo

Kallyope

The company is dedicated to unlocking the potential of the gut-brain axis using cutting-edge technologies for the development of therapeutics and products.

Orcabio-Logo

Orca Bio

A clinical-stage biotechnology company developing a pipeline of high-precision allogeneic cell therapy products.

Source: Nasdaq Private Market Tape D™